AIM
AVNS icon

AXA Investment Managers’s Avanos Medical AVNS Stock Holding History

AXA Investment Managers’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$137K Buy
+11,886
New +$139K ﹤0.01% 1108

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

AXA Investment Managers's AVNS Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Avanos Medical (AVNS) in Q3 2025: 11,886 shares worth $137K. The stake represents ﹤0.01% of the portfolio and ranks #1108 among its holdings.

276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

  • AXA Investment Managers held 11,886 shares of Avanos Medical worth $137K as of Q3 2025.
  • Avanos Medical was a new AXA Investment Managers position in Q3 2025.
  • Avanos Medical made up ﹤0.01% of AXA Investment Managers's portfolio in Q3 2025, its #1108 holding.
  • 276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.